pulmonologyadvisor5 天
In PAH, Early Use of Parenteral Prostacyclin Therapy Is Beneficial
At initiation of parenteral prostacyclin therapy, 62% of patients had intermediate-high COMPERA 2.0 risk status, whereas at ...